Colistin - That Was Fun, But Now We're Done.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 38320089.
- Also identified by DOI 10.1056/EVIDe2200298.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antimicrobial resistance (AMR) is an increasing global threat with estimates that drug-resistant infections contribute to nearly 5 million deaths worldwide every year.<sup>1</sup> In particular, carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) is emerging as a challenging pathogen to treat and has been designated by the World Health Organization as a priority pathogen for the development of new antimicrobial agents.<sup>2</sup> Studies evaluating the efficacy of therapeutic strategies are vitally important in the fight against drug-resistant <i>A. baumannii</i> and other drug-resistant infections.
Medical subject headings
- Acinetobacter Infections
- Acinetobacter baumannii